IDEAYA Biosciences (IDYA) Retained Earnings (2018 - 2026)

IDEAYA Biosciences has disclosed Retained Earnings across 9 years of filings, most recently posting -$835.1 million for Q1 2026.

• Retained Earnings for Q1 2026 came in at -$835.1 million, down 20.16% year-over-year; the trailing twelve-month figure through Mar 2026 was -$835.1 million (down 20.16% YoY), and the FY2025 annual result was -$736.5 million, down 90806.77% from the prior year.
• Retained Earnings came in at -$835.1 million for Q1 2026 at IDEAYA Biosciences, down from -$736.5 million in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of $3.8 million in Q3 2024 to a low of -$835.1 million in Q1 2026.
• The 5-year median for Retained Earnings is -$4.0 million (2022), against an average of -$215.3 million.
• Peak annual rise in Retained Earnings reached 207.42% in 2025, while the deepest fall reached 90806.77% in 2025.
• IDEAYA Biosciences' Retained Earnings stood at -$2.9 million in 2022, then surged by 119.58% to $562000.0 in 2023, then jumped by 44.48% to $812000.0 in 2024, then sank by 90806.77% to -$736.5 million in 2025, then decreased by 13.38% to -$835.1 million in 2026.
• The last three Retained Earnings figures came in at -$835.1 million (Q1 2026), -$736.5 million (Q4 2025), and $2.1 million (Q3 2025), per Business Quant data.